Filing Flows › Lifecore Biomedical (LFCR) › Capital expenditures
Lifecore Biomedical (LFCR) capital expenditures by quarter
Lifecore Biomedical's capital expenditures were $912K in Q1 FY27 (first quarter fiscal 2027), -18% from Q3 FY26. Over the last 5 quarters it ranged from $912K (Q1 FY27) to $5.5M (Q3 FY25).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $912K | -18% | -47% |
| Q3 FY26 | $1.1M | -36% | -80% |
| Q1 FY26 | $1.7M | -17% | — |
| Q4 FY25 | $2.1M | -62% | — |
| Q3 FY25 | $5.5M | — | — |
Q1 FY27 at a glance
Lifecore Biomedical, Q1 FY27: revenue $25.3M (-19% year over year), operating margin -3.5%, net loss $40.1M, operating cash flow $6.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Lifecore Biomedical's capital expenditures?
Lifecore Biomedical's capital expenditures were $912K in Q1 FY27 (first quarter fiscal 2027), -18% from Q3 FY26.
How has Lifecore Biomedical's capital expenditures changed?
Over the last 5 quarters it ranged from $912K (Q1 FY27) to $5.5M (Q3 FY25).